Multiple Myeloma and Exercise
NCT01809717 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2020-03-10
Summary
This study will establich the feasibility of weight lifting exercise among patients with multiple myeloma, determine if weight lifting exercise increases lean body mass among patients with multiple myeloma and obtain further preliminary data on toxicity and pharmacokinetics of high-dose melphalan.
Conditions
- Newly Diagnosed Multiple Myeloma
Interventions
- OTHER
-
Weight Lifting Exercises
Sponsors & Collaborators
-
Abramson Cancer Center at Penn Medicine
lead OTHER
Principal Investigators
-
Dan Vogl · Abramson CC
Study Design
- Allocation
- NA
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-03-31
- Primary Completion
- 2013-08-31
- Completion
- 2013-08-31
Countries
- United States
Study Locations
More Related Trials
-
Autologous Transplant for Multiple Myeloma
NCT00177047 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Melphalan, Total Marrow Irradiation, and Autologous Stem Cell Transplantation in Treating Patients With High-Risk Multiple Myeloma
NCT03100877 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Assessing the Impact of a Financial Navigation Program for Patients With Multiple Myeloma
NCT05448196 ·Status: COMPLETED ·Phase: NA
-
Total Marrow Irradiation and High-dose Melphalan for Double Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
NCT01665014 ·Status: UNKNOWN ·Phase: PHASE2
-
Back Pain Prevention in Multiple Myeloma Using an External Spinal Brace
NCT02898064 ·Status: COMPLETED ·Phase: NA
-
Panobinostat and Carfilzomib in Treating Participants With Relapsed or Refractory Multiple Myeloma
NCT01301807 ·Status: COMPLETED ·Phase: PHASE1
-
Lenalidomide and Melphalan in Treating Patients With Previously Untreated Multiple Myeloma
NCT00305812 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating the Uptake and Utility of Clinical Pathways for Newly Diagnosed Patients With Multiple Myeloma
NCT06149910 ·Status: RECRUITING
-
The Myeloma Pack: A Multi-Modality Educational Intervention Strategy to Engage Patients With Multiple Myeloma
NCT03777306 ·Status: COMPLETED ·Phase: NA
-
Patient and Care Partner Experiences Living With Multiple Myeloma (PaCE-MM)
NCT05276622 ·Status: TERMINATED
-
Combination Chemotherapy With or Without High Dose Cyclophosphamide and Recombinant Interferon Alfa-2b in Treating Patients With Previously Untreated Stage I-III Multiple Myeloma
NCT00002556 ·Status: COMPLETED ·Phase: PHASE3
-
Combination Chemotherapy With or Without Cyclophosphamide and Prednisone in Treating Older Patients With Multiple Myeloma
NCT00002653 ·Status: UNKNOWN ·Phase: PHASE3
-
Autologous Stem Cell Transplantation and Maintenance Therapy for Multiple Myeloma
NCT01617213 ·Status: TERMINATED ·Phase: PHASE2
-
Phase 1/2a Study of Cancer Vaccine to Treat Smoldering Multiple Myeloma
NCT01718899 ·Status: COMPLETED ·Phase: PHASE1
-
Rehabilitation Management for Patients with Multiple Myeloma
NCT06838065 ·Status: COMPLETED
-
Etiology of Multiple Myeloma: A Case-Control Study
NCT00505999 ·Status: UNKNOWN
-
Study of the Safety and Efficacy of an Investigational Drug in Adult Patients With Multiple Myeloma
NCT00036140 ·Status: COMPLETED ·Phase: PHASE1
-
Carfilzomib + High Dose Melphalan as Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation
NCT01690143 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
S1211 Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma
NCT01668719 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Stopping Maintenance Therapy in People With Multiple Myeloma in MRD-Negative Remission
NCT04221178 ·Status: ACTIVE_NOT_RECRUITING
-
The Burden of Multiple Myeloma on Patients and Caregivers Quality of Life: a Canadian Real-World Study
NCT06610045 ·Status: COMPLETED
-
Studying T Cells in Blood and Bone Marrow Samples From Patients With Multiple Myeloma
NCT00897910 ·Status: TERMINATED
-
Dovitinib Combined With Bortezomib and Dexamethasone for Relapsed/Refractory Multiple Myeloma
NCT01680796 ·Status: WITHDRAWN ·Phase: PHASE1
-
Combination Chemotherapy and Donor Stem Cell Transplant Followed by Ixazomib Citrate Maintenance Therapy in Treating Patients With Relapsed High-Risk Multiple Myeloma
NCT02504359 ·Status: COMPLETED ·Phase: PHASE1
-
A Dietary Study for People With Multiple Myeloma
NCT07226609 ·Status: RECRUITING ·Phase: NA